News

Kiniksa Pharmaceuticals Sponsors American Heart Association’s Addressing Recurrent Pericarditis Initiative

– Initiative aimed at improving access and outcomes for patients with recurrent pericarditis – – American Heart Association to work with…

5 months ago

Microbot Medical Announces Brigham and Women’s Hospital as a Site for its Pivotal Human Clinical Trial

The Site Initiation Visit for the BWH clinical staff is complete and a shipment of LIBERTY investigational units was deliveredBRAINTREE,…

5 months ago

Goodness Growth Holdings Announces Closing of Recently Announced Non-Brokered Private Placement

– Company also receives short extension of its credit agreement until July 31, 2024 –MINNEAPOLIS, June 17, 2024 (GLOBE NEWSWIRE)…

5 months ago

RENNOVA HEALTH, INC. ANNOUNCES STOCK EXCHANGE AGREEMENTS WITH FOXO TECHNOLOGIES, INC. FOR TWO OPERATING SUBSIDIARIES

WEST PALM BEACH, Fla., June 17, 2024 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) is pleased to announce that…

5 months ago

Prenetics Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

~ Emphasizes Strong Cash Position, No Debt, and A Dedicated Management Team Focused on Delivering Growth and Value to Shareholders…

5 months ago

Pancreatic cancer’s cellular amnesia

COLD SPRING HARBOR, N.Y., June 17, 2024 /PRNewswire/ -- Things aren't always as they seem. Take pancreatic cancer, for example. In…

5 months ago

Trustworthy and Responsible AI Network expands to help European healthcare organizations enhance the quality, safety and trustworthiness of AI in health

AMSTERDAM, June 17, 2024 /PRNewswire/ -- Monday, at HLTH Europe, the Trustworthy & Responsible AI Network (TRAIN), a consortium of healthcare…

5 months ago

XRP Healthcare Magazine Issue 3: Featuring Ugandan Innovator Peter Waiswa, NHS Collaborator ISANSYS, Ehlers-Danlos Society & Top 10 African Hospitals

DUBAI, UAE, June 17, 2024 /PRNewswire/ -- XRP Healthcare proudly announces the release of Issue 3 of the highly anticipated…

5 months ago

Defence’s Chief Scientific Officer Dr. Moutih Rafei Discusses the Accum Platform for Cancer Treatments on Money Talk Radio with Ellis Martin

Vancouver, British Columbia--(Newsfile Corp. - June 17, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or…

5 months ago

Updated Linvoseltamab Data Showcase Continued Deepening of Responses in Patients with Heavily Pre-Treated Multiple Myeloma

At 14-months median follow-up in the pivotal trial, 50% of patients achieved a complete response or better and a 71%…

5 months ago